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Chapter	  one:	  Introduction	  of	  iron-­‐containing	  superoxide	  dismutase	  (FeSOD)	  Oxygen	  is	  essential	  for	  cellular	  respiration	  in	  all	  kinds	  of	  aerobic	  organisms.	  Oxygen	   is	   a	   spin	   triplet	   in	   its	  ground	  state	   so	   reactions	   that	  generate	  only	   closed-­‐shell	  products	  (singlets)	  are	  formally	  forbidden.	   	  However,	  one-­‐electron	  reduction,	  of	   oxygen	   produces	   a	   free	   radical	   that	   can	   undergo	   spin	   recombination	   to	   yield	  singlet	   product.	   	   	   Thus	   the	   superoxide	   (O2−)	   intermediate	   provides	   a	   means	   of	  reconciling	   spin1.	   In	   biological	   systems,	   O2−	   is	   generated	   by	   several	   processes2.	  	  Autoxidation,	   for	   example	   of	   myoglobin3,	   hemoglobin4,	   reduced	   cytochrome	   C5,	  reduced	  ferredoxins6	  or	  tetrahydropterins7	  can	  produce	  O2−	  upon	  reaction	  with	  O2.	  Some	   enzymes,	   such	   as	   xanthine	   oxidase,	  may	   produce	  O2−	   during	   their	   catalytic	  cycles8.	  Some	  organelles,	  such	  as	  mitochondria	  and	  chloroplasts,	  are	  also	  known	  to	  generate	  O2−.	  Actually,	  O2−	   is	   not	   as	   reactive	   as	  people	   thought.	   It’s	   only	   reactive	  within	  several	  amino	  acids	  where	  it	  is	  generated.	  However,	  since	  O2−	  can	  initiate	  a	  free	  radical	  chain	  reaction,	  it	  can	  generate	  other	  more	  toxic	  radicals,	  which	  are	  more	  harmful	   to	   the	   organisms.	   There	   are	   two	  main	   radicals	   O2−	   can	   generate,	   one	   is	  perhydroxyl	   radical	   (HO2)9	   and	   the	   other	   is	   hydroxyl	   radical	   (OH).	   Haber	   and	  Weiss	  were	  the	  first	  to	  propose	  that	  O2−	  and	  hydrogen	  peroxide	  (H2O2)	  can	  react	  to	  produce	  hydroxyl	   radical	  via	   the	  reaction	  𝑂!! + 𝐻!𝑂! → 𝑂𝐻! + 𝑂𝐻 + 𝑂!.	  Because	  it	  is	  so	  reactive,	  OH	  can	  amplify	  the	  potential	  dangers	  of	  O2−	  10.	  Because	   of	   these	   toxicities,	   a	   kind	   of	   enzyme	   called	   superoxide	   dismutase	  (SOD)	   is	   used	   in	   respiring	   cells	   to	   defend	   against	   O2−	   radicals.	   SOD	   can	  enzymatically	   enhance	   the	   rate	   of	   O2−	   disproportionation11	   (𝑂!! + 𝑂!! + 2𝐻! →𝐻!𝑂! + 𝑂! ).	   There	   are	   three	   types	   of	   superoxide	   dismutase	   among	   present	  organisms	  and	  they	  differ	  with	  respect	  to	  the	  metal	  co-­‐factor	  they	  employ	  as	  well	  as	  the	  protein	  fold:	  copper-­‐zinc	  SODs	  (CuZnSODs),	  manganese	  or	  iron	  SODs	  (MnSODs	  or	   FeSODs),	   and	   nickel	   SOD	   (NiSODs)12.	   Fe-­‐	   and	   MnSODs	   are	   the	   most	   widely	  distributed	  SOD	  of	  the	  three	  enzymes,	  and	  they	  can	  be	  found	  in	  all	  five	  kingdoms	  of	  life13.	   MnSODs	   typically	   can	   be	   found	   in	  mitochondria14	   and	   bacteria	  where	   their	  function	  is	  protecting	  DNA	  from	  endogenous	  oxidative	  stress.	  FeSODs	  are	  normally	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found	   in	   bacteria,	   protists	   and	   chloroplasts	   to	   defend	   them	   from	   local	   oxidative	  stress15.	  NiSODs	  are	  the	  most	  recently	  identified	  SODs,	  being	  found	  in	  Streptomyces	  and	  related	  species16,17.	  Our	   group	   is	   dedicated	   to	   the	   study	   of	   MnSOD	   and	   FeSOD.	   	   The	   current	  project	   focuses	   on	   FeSOD.	   FeSOD	   was	   first	   discovered	   by	   Fridovich's	   group18	   in	  1973	   in	   Escherichia	   coli	   B,	   three	   years	   after	   the	   discovery	   of	   MnSOD19.	   Early	   on,	  FeSODs	   were	   found	   to	   be	   dimers	   with	   1-­‐2	   atoms	   of	   iron	   per	   dimer18,20.	   X-­‐ray	  crystallography	   revealed	   the	   structure	   of	   FeSOD21-­‐27.	   The	   FeSOD	   monomer	   is	  approximately	  22	  kDa	  and	  fully	  folded	  into	  a	  3D	  structure,	  which	  is	  shown	  in	  Figure	  1.1.	   Three	   α-­‐helices	   a1,	   a2	   and	   a3	   are	   formed	   in	   the	   N-­‐terminal	   domain.	   A	   short	  linker	  with	  about	  10	  amino	  acids	  connects	  the	  N-­‐terminal	  domain	  with	  C-­‐terminal	  domain.	  In	  the	  C-­‐terminal	  domain,	  two	  α-­‐helices	  (a4	  and	  a5)	  are	  next	  to	  the	  linker,	  followed	  by	  3	  β	  sheets	  (b1,	  b2	  and	  b3).	  Two	  more	  α-­‐helices	  (a6	  and	  a7)	  finish	  the	  C-­‐terminal	  domain.	  Active	  site	  iron	  atom	  in	  the	  monomer	  is	  located	  between	  N	  and	  C-­‐terminal	   domains.	   N-­‐terminal	   provides	   two	   ligands	   to	   iron.	   The	   first	   α-­‐helix	   a1	  provides	   His26	   as	   one	   ligand	   and	   α-­‐helix	   a3	   provides	   His73	   as	   another.	   The	   C-­‐terminal	  domain	  supplies	  the	  other	  2	  ligands:	  Asp156	  and	  His60.	   	  Besides	  the	  four	  ligands	  provided	  by	  the	  protein,	  a	  coordinated	  solvent	  molecule	  serves	  as	  the	  fifth	  ligand	   (Figure	   1.2).	   The	   five	   ligands	   form	   a	   trigonal	   bipyramidal	   coordination	  sphere,	  with	  His26	  and	  coordinated	  solvent	  in	  the	  axial	  positions28.	  Studies	  showed	  that	   the	   coordinated	   solvent	   molecule	   is	   OH−	   when	   iron	   is	   in	   the	   oxidized	   state	  (Fe3+),	   and	  H2O	  when	   iron	   is	   in	   the	   reduced	   state	   (Fe2+)23,29.	   Studies	   also	   showed	  that	   the	   2nd	   coordination	   sphere	   around	   the	   active	   site	   plays	   a	   significant	   role	  though	   hydrogen	   binding25,30-­‐34(Figure	   1.3).	   Hydrogen	   bond	   network	   is	   extended	  from	   the	   coordinated	   solvent	   in	   the	   active	   site	   to	   the	  2nd	   sphere	  by	  Gln69,	  Tyr34,	  Asn72,	   Trp122.	   Among	   these	   amino	   acids,	   Gln69	   plays	   an	   important	   role.	   By	  mutating	   Gln69	   to	   histidine,	   the	   former	   group	   member	   Emine	   Yikilmaz	  demonstrated	  that	  the	  hydrogen	  bond	  between	  Gln69	  and	  the	  coordinated	  solvent	  molecule	  could	  strongly	  influence	  FeSOD	  activity33.	  FeSOD	  employs	  a	  ping-­‐pong	  mechanism35.	  The	  first	  half	  reaction	  involves	  the	  oxidation	  of	  substrate	  O2−	  and	  the	  reduction	  of	  the	  metal	  ion	  co-­‐factor	  in	  the	  active	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site.	  From	  the	  substrate's	  perspective,	  this	  reaction	  only	  requires	  electron	  transfer.	  Since	   net	   charge	   near	   the	   active	   site	   of	   FeSOD	   is	   positive,	   this	   half	   reaction	   is	  favorable.	  	  However	  the	  enzyme	  takes	  up	  a	  proton	  in	  conjunction	  with	  reduction	  of	  the	  active	  site	  Fe36.	  On	  the	  other	  hand,	  simple	  reduction	  of	  O2−	  is	  not	  favorable	  .	  By	  providing	   2	   protons	   to	   produce	   H2O2,	   FeSOD	   makes	   the	   second	   half	   reaction	  favorable	  as	  well.	  𝑂!! + 𝐹𝑒!!𝑆𝑂𝐷 → 𝑂! + 𝐹𝑒!!𝑆𝑂𝐷	   	   	   	   	   	   (1)	  𝑂!! + 𝐹𝑒!!𝑆𝑂𝐷 + 2𝐻! → 𝐻!𝑂! + 𝐹𝑒!!𝑆𝑂𝐷	   	   	   	   (2)	  Although	  O2−	  is	  the	  actual	  substrate	  in	  the	  reaction,	  its	  short	  lifetime	  makes	  it	  hard	  to	  study.	  Substrate	  analogues	  have	  been	  studied	  to	  understand	  the	  binding	  behavior.	   One	   of	   the	   substrate	   analogues	   is	   azide	   (N3−).	   Studies	   showed	   that	   one	  azide	   molecule	   could	   bind	   directly	   to	   the	   active	   site	   iron	   and	   inhibit	   FeSOD	  completely25,37-­‐40.	  Another	  useful	  substrate	  analogue	  is	  fluoride	  (F−);	  two	  F−	  ions	  can	  bind	   to	   the	   active	   site	   iron	   and	   one	   is	   believed	   to	   replace	   the	   coordinated	  solvent37,38.	  Electron	  paramagnetic	   resonance	   (EPR)	   is	  one	  of	   the	  methods	   to	   study	   the	  active	   site	   electronic	   structure	   and	   coordination	   geometry	   of	   FeSOD,	   since	   Fe3+	   is	  paramagnetic.	   	   EPR	   spectra	   have	   been	   used	   to	   compare	   active	   the	   active	   sites	   of	  FeSODs	  from	  different	  organisms41.	  The	  signal	  observed	  near	  1500	  G	  when	  using	  a	  microwave	   frequency	   near	   9	   GHz	   ('X-­‐band')	   is	   a	   signature	   of	   the	   spin	   transition	  between	  ms	  =	  ±3/2	  states	  of	  the	  S=5/2	  Fe3+.	  The	  reaction	  of	  H2O2	  with	  Fe3+SOD	  has	  also	  been	  studied	  by	  EPR.	  Some	  of	  the	  studies	  indicated	  that	  only	  EPR	  signal	  intensity	  was	  decreased	  upon	  adding	  H2O242.	  On	  the	  other	  hand,	  some	  studies	  showed	  that	  H2O2	  can	  inhibit	  FeSOD	  completely43,44.	  EPR	  is	  also	  a	  powerful	  tool	  for	  studying	  anion	  binding40	  and	  the	  pH	  dependence	  of	  Fe3+SOD45-­‐47.	  It	  showed	  that	  OH-­‐	  coordinates	  to	  Fe3+	  when	  the	  pH	  is	  increased	  from	  neutral	   pH	   to	   high	   pH,	   and	   the	   geometry	   changed	   from	   five-­‐coordinate	   to	   six-­‐coordinate.	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Figure	   1.2:	  Ribbon	  structure	  of	  E.	  coli	   Fe3+SOD	  dimer	   showing	   the	  Fe3+	  as	  a	   large	  orange	   sphere	   and	   the	   heavy	   atoms	   of	   the	   ligands	   from	   Cα	   out	   in	   ball	   and	   stick	  format.	   Based	   on	   the	   coordinates	   of	   Fe3+SOD	   published	   by	   Lah	   et	   al.,	   1ISB,25	   and	  produced	  by	  Miller,	  A.	  F.28	  using	  MOLSCRIPT.	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  Figure	  1.3:	  The	  active	  site	  including	  selected	  second	  sphere	  residues	  in	  FeSOD	  with	  commonly-­‐reported	  hydrogen	  bonds.	  H	  atoms	  and	  backbone	  atoms	  are	  omitted	  for	  clarity.	   Based	   on	   the	   coordinates	   of	   Fe3+SOD	   published	   by	   Lah	   et	   al.,	   1ISB,25	   and	  produced	  by	  Miller,	  A.	  F.28	  using	  MOLSCRIPT.	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Chapter	  two:	  Optimization	  of	  FeSOD	  growth	  and	  purification	  
2.1	  Introduction	  The	  active	  site	  Fe	  of	  FeSOD	  is	  essential	  for	  catalytic	  activity.	  Thus	  acquisition	  of	  Fe	  is	  a	  key	  step	  in	  maturation	  for	  FeSOD.	  According	  to	  the	  X-­‐ray	  crystal	  structure,	  the	  mature	  FeSOD	  should	  be	  a	  dimer	  with	  one	   iron	   ion	   in	  each	  of	   the	  active	  sites.	  Since	  the	  first	  discovery	  of	  FeSOD	  by	  the	  Fridovich	  group	  in	  197318,	  “iron-­‐containing	  superoxide	  dismutases	  have	  been	  isolated	  from	  a	  variety	  of	  microbial	  sources,	  and	  in	  each	   instance	  1	   to	  2	  atoms	  of	   	   iron	  per	  molecule	  are	   found”37.	  Different	  growth	  and	   purification	   conditions	   may	   affect	   metal	   ion	   uptake,	   and	   thereby	   alter	   the	  activity	   of	   FeSOD.	   In	   the	   beginning	   of	   the	   project,	   different	   culture	   growth	   and	  purification	   conditions	   were	   tested	   to	   maximize	   the	   metal	   uptake	   and	   enzyme	  maturation.	  
2.2	  Materials	  and	  Methods	  
2.2.1	  Materials	  and	  apparatus	  The	   wild	   type	   FeSOD	   gene	   is	   encoded	   on	   the	   pRLK1-­‐3	   vector.	   E.	   coli	  BL21(DE3)	  harboring	  plasmid	  pRLK1-­‐3	  was	  obtained	  from	  stock	  solution	  prepared	  by	  R.	  L.	  Koder.	  The	  plasmid	  pRLK1-­‐3	  carries	  kanamycin	  resistance.	  	  BL21	  (DE3)	  competent	  cells	  were	  purchased	  from	  Novagen	  and	  stored	  at	  -­‐20	  °C.	   Isopropyl	   β-­‐thiogalactopyranoside	   (IPTG),	   kanamycin,	   and	   4-­‐(2-­‐	   Aminoethyl)	  benzenesulfonyl	   fluoride	   hydrochloride	   (AEBSF)	   were	   purchased	   from	   Sigma.	  Bradford	  reagent	  and	  BSA	  used	  for	  protein	  quantitation	  were	  obtained	  from	  sigma.	  All	   other	   chemicals	   were	   biological	   grade	   and	   purchased	   from	   ACROS	   organics,	  Research	  Organics	  or	  Sigma-­‐Aldrich.	  A	   Mettler	   Toledo	   Model	   AB54	   analytical	   balance	   was	   used	   for	   weight	  measurements.	   	   Deionized	   water	   used	   in	   the	   experiments	   was	   purified	   using	   a	  Millipore	  Milli-­‐Q	  Plus	  System.	  All	  bacterial	  cells	  were	  incubated	  and	  grown	  at	  37	  °C	  in	  a	  National	  Heinicke	  Model	  3321	  incubator.	  The	  shaking	  incubator	  used	  is	  a	  New	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Brunswick	  Scientific	  C25	   Incubator	  Shaker.	  Cells	  were	  harvested	  by	  centrifugation	  in	   a	   Beckman	   Coulter	   J-­‐25I	   Centrifuge.	   Bacterial	   cells	   were	   ruptured	   by	   passage	  through	   a	   French	   Press	   from	   SLM-­‐AMINCO	   Spectronic	   Instruments.	   An	   HP8452B	  diode	   array	   spectrophotometer	  was	  used	   to	  determine	   the	  optical	   density	  of	   cells	  and	  to	  measure	  protein	  concentrations.	  	  
2.2.2	  Methods	  Protein	   overexpression	   was	   initiated	   by	   plating	   the	   E.	   coli	   BL21(DE3)/	  pRLK1-­‐3	  glycerol	  stock	  solution	  on	  an	  Luria-­‐Bertani	  (LB)	  plate	  containing	  50	  μg/mL	  kanamycin	  and	  incubating	  at	  37	  °C	  overnight.	  A	  single	  colony	  was	  used	  to	  inoculate	  a	   tube	   of	   3	   mL	   LB	   medium	   (Bactro-­‐tryptone	   5g/500mL,	   Bacto-­‐yeast	   extract	  2.5g/500ml,	   NaCl	   5g/500mL,	   pH=7.5)	   containing	   50	   μg/mL	   kanamycin.	   After	  incubation	  at	  37	  °C,	  shaking	  at	  220	  rpm	  for	  12	  hours,	  100	  μL	  were	  used	  to	  inoculate	  100	  mL	   of	   LB	   culture	   containing	   50	   μg/mL	   kanamycin.	   After	   incubation	   at	   37	   °C,	  shaking	  at	  220	   rpm	   for	   another	  12	  hours,	   50	  mL	  LB	   culture	  was	  added	   to	  2	  L	  LB	  medium	  containing	  50	  μg/mL	  kanamycin	  and	   then	   shaken	  at	  37	   °C	   in	   a	  6	  L	   flask.	  When	   the	   optical	   density	   at	   600	   nm	   (OD600)	   reached	   approximately	   0.6,	   ferrous-­‐nitrilotriacetate	  (Fe-­‐NTA)	  was	  added	  to	  a	  final	  concentration	  of	  35	  μM	  and	  isopropyl	  β-­‐thiogalactopyranoside	   (IPTG)	   was	   added	   to	   a	   final	   concentration	   of	   0.5	   mM	   to	  induce	  SOD	  overexpression.	  The	  culture	  was	  shaken	  at	  37	  °C,	  220	  rpm	  for	  another	  10-­‐12	  hours.	  The	  cells	  were	  harvested	  by	  centrifugation	  at	  4	  °C,	  at	  9500	  rpm	  for	  15	  min.	  The	  cells	  were	  re-­‐suspended	  in	  cell	  wash	  buffer	  (50	  mM	  potassium	  phosphate	  buffer,	  pH=7.4),	   collected	  via	   centrifugation	  at	  9,500	  rpm	  and	  4°C	   for	  15	  min,	   and	  frozen	   at	   -­‐20°C	   until	   needed.	   The	   level	   of	   overexpression	   was	   tested	   by	   running	  sodium	  dodecyl	  sulfate	  polyacrylamide	  gel	  electrophoresis	   (SDS-­‐PAGE)	  of	  samples	  collected	  before	  and	  after	  adding	  IPTG.	  Frozen	   cells	   were	   re-­‐suspended	   in	   cell	   lysis	   buffer	   (50	   mM	   potassium	  phosphate	   pH=7.4,	   0.5%	   NaCl	   (w/v),	   0.5%	   KCl	   (w/v),	   1	   mM	   EDTA)	   with	   a	   final	  concentration	  0.2	  mg/mL	  4-­‐(2-­‐Aminoethyl)	  benzenesulfonyl	  fluoride	  hydrochloride	  (AEBSF).	  Approximately	  3	  ml	  of	  cell	  lysis	  buffer	  were	  used	  for	  each	  1	  g	  of	  cell	  paste.	  The	  mixture	  was	  transferred	  to	  a	  homogenizer	  and	  ground	  to	  a	  smooth	  paste.	  Cells	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were	  broken	  by	  passage	  through	  a	  French	  Press	  3	  times	  at	  10000	  to	  15000	  psi.	  The	  crude	  SOD	  was	  separated	  from	  cell	  debris	  by	  centrifugation	  at	  4	  °C,	  18000×g	  for	  30	  min.	   Potassium	   chloride	   (KCl)	   was	   gradually	   added	   to	   the	   supernatant	   while	  stirring	   untill	   the	   concentration	   of	   KCl	   reached	   0.1	   M	   (calculation	   without	  accounting	  for	  KCl’s	  contribution	  to	  the	  volume).	  The	  mixture	  was	  transferred	  to	  a	  beaker	   in	  50	   °C	  water	  bath	   for	  3	  min	  with	  occasional	   swirling,	   followed	  by	  an	   ice	  bath	  for	  15	  min	  without	  swirling.	  	  Precipitated	  proteins	  were	  separated	  from	  crude	  FeSOD	  by	  centrifugation	  at	  4	  °C,	  18000×g	  for	  30	  min.	  Ammonium	   sulfate	   ((NH4)2SO4)	   was	   gradually	   added	   to	   the	   supernatant	  while	   stirring	   until	   the	   solution	   was	   50%	   saturated	   by	   ((NH4)2SO4	   to	   precipitate	  additional	  undesired	  proteins	  .	  The	  crude	  FeSOD	  and	  the	  cell	  debris	  were	  separated	  by	  centrifugation	  at	  4	  °C,	  18000×g	  for	  30	  min.	  The	  supernatant	  was	  applied	  to	  a	  100	  mL	  G-­‐25	  desalting	  column,	  which	  had	  been	   pre-­‐equilibrated	   with	   3	   volumes	   of	   5	   mM	   potassium	   phosphate	   buffer	  (pH=7.4).	   The	   flow-­‐through	   fractions	  were	   collected	   in	   small	   tubes	   (each	   fraction	  was	   about	   5	  mL),	   and	   their	   A280	   values	  were	  measured	   using	   an	   HP8452B	   diode	  array	  spectrophotometer	  to	  identify	  fractions	  containing	  protein	  (ε280	  =	  101,000	  M-­‐1cm-­‐1	  37).	  The	  eluted	  SOD	  protein	  was	  identified	  on	  the	  basis	  of	  its	  molecular	  weight	  by	  SDS-­‐PAGE	  and	  its	  yellow	  color.	  Fractions	  containing	  SOD	  protein	  were	  combined	  and	   dialyzed	   against	   12	   L	   dialysis	   buffer	   (5mM	   potassium	   phosphate,	   pH=7.4)	  overnight	  at	  4	  °C.	  The	  dialyzed	  protein	  was	  concentrated	  using	  an	  Amicon	  Ultra-­‐15	  centrifugal	  filter	  device	  (10k	  nominal	  molecular	  weight	  limit)	  by	  centrifuging	  at	  4	  °C	  at	  4000×g	  for	   20	  min,	   to	   a	   final	   volume	   of	   less	   than	   10	  mL.	   The	   protein	   concentration	  was	  determined	  based	  on	  the	  A280	  and	  the	  active	  site	  Fe3+	  concentration	  was	  determined	  via	  the	  A350	  (ε350	  =	  1850	  M-­‐1cm-­‐1/dimer37).	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2.3	  Results	  and	  discussions	  
2.3.1	  Final	  concentration	  of	  IPTG	  IPTG	  was	  used	  to	  induce	  the	  production	  of	  FeSOD	  protein.	  Normally,	  IPTG	  is	  used	  as	  an	  inducer	  in	  the	  concentration	  range	  of	  0.1	  mM	  to	  1.5	  mM.	  Different	  final	  concentrations	   of	   IPTG	   may	   be	   used	   to	   modulate	   the	   induction	   strength	   and	   to	  accommodate	   the	   features	   of	   the	   expression	   system48,49.	   However,	   there	   was	   no	  published	   study	   to	   show	   how	   the	   concentration	   of	   IPTG	   affects	   bacterial	  overexpression	   of	   FeSOD.	   In	   the	   experiment,	   0.5	   mmol/L	   and	   1.0	   mmol/L	   final	  concentrations	   of	   IPTG	   were	   used	   for	   two	   otherwise	   identical	   bacterial	   cultures	  when	  the	  optical	  density	  at	  600	  nm	  (OD600)	  reached	  0.5,	  to	  induce	  the	  production	  of	  FeSOD.	   	   The	   OD600	  was	  monitored	   and	   plotted	   against	   time.	   The	   culture	  with	   0.5	  mmol/L	  IPTG	  produced	  about	  10%	  more	  of	  bacterial	  cells	  than	  1.0	  mmol/L	  IPTG.	  	  In	   conjunction	  with	  determinations	  of	   the	  optical	   density,	   1	  mL	  of	   samples	  were	  collected	  and	  spun	  down	  to	  harvest	  the	  bacterial	  cells	  in	  each	  sample.	  All	  the	  cell	  pellets	  were	  treated	  with	  dithiothreitol	  and	  SDS	  to	  lyse	  the	  cells	  and	  then	  loaded	  onto	  a	  SDS-­‐PAGE	  gel.	  The	  results	   from	  SDS-­‐PAGE	  were	  consistent	  with	  the	  growth	  curve	   in	   that	   the	   0.5	   mmol/L	   final	   concentration	   of	   IPTG	   induced	   slightly	   more	  FeSOD	  protein	  than	  1.0	  mmol/L	  IPTG.	  Therefore,	  all	  subsequent	  growths	  employed	  0.5	  mmol/L	  IPTG	  as	  final	  concentration.	  	  
2.3.2	  Different	  amounts	  of	  aeration	  during	  the	  LB	  growth	  Since	  oxygen	   is	  an	  essential	   ingredient	   for	   the	  growth	  of	  most	  bacteria,	   the	  extent	  of	  aeration	  of	  the	  growth	  system	  may	  affect	  the	  protein	  yield.	  However,	  iron	  is	  less	  soluble	  in	  aerobic	  than	  anaerobic	  medium.	  In	  this	  experiment,	  2	  L	  LB	  in	  a	  6	  L	  flask	   and	   1	   L	   LB	   in	   a	   6	   L	   flask	   were	   compared	   to	   test	   the	   effect	   of	   aeration	   on	  bacterial	  growth.	  The	  results	  in	  Figure	  2.1	  showed	  that	  less	  aeration	  corresponding	  to	  2	  L	  of	  LB	  medium	   in	  a	  6	  L	   flask	  worked	  better	   than	  1	  L	  of	  LB	  medium	   in	  a	  6	  L	  flask.	  All	  subsequent	  growths	  were	  executed	  using	  2	  L	  of	  LB	  medium	  in	  a	  6	  L	  flask.	  
2.3.3	  Different	  heat-­‐cut	  temperatures	  in	  the	  purification	  process	  SOD	   is	   a	   robust	   enzyme	   and	   can	   tolerate	   higher	   temperatures	   than	   most	  proteins.	   Therefore,	   a	   heat-­‐cut	   step	   was	   included	   in	   the	   purification	   process	   to	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eliminate	  other	  undesired	  proteins	  by	  Fee	  et	  al.37	  to	  improve	  the	  purity	  of	  FeSOD.	  To	  optimize	   the	   performance	   of	   this	   step,	   temperatures	   50,	   60,	   70	   and	   80	   °C	   were	  compared.	   Four	   identical	   batches	   of	   protein	   solutions	   from	   the	   French	   press	   step	  were	   treated	   with	   one	   of	   the	   above	   temperatures,	   each.	   No	   matter	   what	   the	  temperature,	   the	   majority	   of	   FeSOD	   stayed	   in	   the	   supernatant.	   Non-­‐denaturing	  PAGE	  was	  used	  to	  assess	  the	  results	  (Figure	  2.2).	  Although	  there	  was	  no	  significant	  difference	   among	   the	   four	   temperatures,	   a	   larger	   fraction	   of	   FeSOD	   stayed	   in	   the	  supernatant	   when	   the	   lower	   temperature	   was	   used,	   and	   the	   degree	   of	  contamination	   of	   FeSOD	   in	   the	   supernatant	   was	   comparable	   to	   that	   obtained	   at	  higher	   temperatures.	   Therefore,	   50	   °C	   was	   employed	   for	   the	   heat-­‐cut	   in	   all	  subsequent	  purifications.	   	  We	  note	   that	   the	  FeSOD	   is	   close	   to	  pure	  already	  at	   this	  step,	  only	  small	  amounts	  of	  contamination	  proteins	  are	  removed,	  so	  we	  deem	  that	  the	  step	  should	  be	  performed	  with	  the	  minimal	  cost	  to	  FeSOD.	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Figure	   2.2:	   Non-­‐denaturing	   polyacylamide	   gel	   electrophoretograms	   of	   wild-­‐type	  FeSOD.	  Panel	  A	  was	  stained	  with	  Coomassie	  brilliant	  blue	  to	  visualize	  all	  proteins	  as	  dark	  blue	  bands.	   	  Panel	  B	  was	   stained	  using	   the	  NBT	  assay	   that	  produces	  a	  violet	  background	   everwhere	   except	  where	   there	   is	   SOD	   activity,	  which	   is	   visualized	   as	  white	  regions.	  In	  both	  panels	  Lane	  1	  was	  the	  prestained	  SDS-­‐PAGE	  Standards	  (Bio-­‐rad,	  310006667;	  Lane	  2	  was	  the	  supernatant	  at	  80°C	  heat-­‐cut;	  Lane	  3	  was	  the	  pellet	  at	  80°C	  heat-­‐cut;	  Lane	  4	  was	  the	  supernatant	  at	  70°C	  heat-­‐cut;	  Lane	  5	  was	  the	  pellet	  at	  70°C	  heat-­‐cut;	  Lane	  6	  was	  the	  supernatant	  at	  60°C	  heat-­‐cut;	  Lane	  7	  was	  the	  pellet	  at	  60°C	  heat-­‐cut;	  Lane	  8	  was	  the	  supernatant	  at	  50°C	  heat-­‐cut;	  Lane	  9	  was	  the	  pellet	  at	  50°C	  heat-­‐cut.	  	  Note	  that	  in	  each	  case	  there	  is	  much	  more	  supernatant	  than	  pellet	  so	  that	  only	  a	  small	  fraction	  of	  FeSOD	  is	  lost.	  
Chapter	  three:	  Synonymous	  codons	  may	  not	  be	  silent	  
3.1	  Introduction	  In	   1941,	   George	   Beadle	   and	   Edward	   Tatum	   proposed	   a	   hypothesis	   called	  “one	   gene-­‐one	   enzyme”50,	   which	   became	   one	   of	   the	   milestones	   in	   the	   history	   of	  molecular	  biology.	  In	  this	  hypothesis,	  each	  gene	  is	  responsible	  for	  producing	  a	  single	  enzyme.	  This	  hypothesis	  has	  been	  modified	  since	  it	  was	  realized	  that	  one	  gene	  can	  code	  for	  more	  than	  one	  enzyme.	  In	  eukaryotes,	  a	  primary	  transcript	  can	  be	  edited	  to	  produce	   several	  different	  polypeptides,	   so	  one	  gene	   can	  produce	   several	  proteins.	  Later	  on,	  people	  found	  out	  that	  each	  amino	  acid	  is	  presented	  by	  one	  or	  more	  triplets	  of	  nucleotide	  bases	  (called	  “codons”)	  when	  translating	  from	  mRNAs	  to	  proteins.	  For	  example,	  during	   the	   translation	  process,	  when	   the	  mRNA	  displays	   the	   codon	  CTG,	  
A"
1" 2" 3" 4" 5" 6" 7" 8" 9"
B"
1" 2" 3" 4" 5" 6" 7" 8" 9"
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the	   corresponding	   tRNA	   that	   has	   been	   charged	  with	   the	   amino	   acid	   leucine	   by	   a	  tRNA	   synthase	   is	   used	   by	   the	   ribosome	   to	   add	   a	   leucine	   to	   the	   growing	   peptide	  chain.	  Because	  there	  are	  64	  possible	  codons	  possible	  for	  encoding	  20	  amino	  acids,	  one	  same	  amino	  acid	  may	  have	  several	  different	  codons.	  In	  the	  example	  above,	  the	  amino	  acid	  leucine	  is	  coded	  for	  by	  6	  different	  codons.	  Early	   on,	   it	   was	   widely	   assumed	   that	   different	   codons	   for	   one	   amino	   acid	  were	   used	   equally,	   and	   if	   a	  mutation	  did	   not	   change	   the	   sequence	   of	   amino	   acids	  (even	   with	   different	   codons),	   then	   it	   would	   produce	   the	   same	   result.	   In	   fact,	   so-­‐called	  synonymous	  codons	  (encoding	  the	  same	  amino	  acid)	  are	  utilized	  to	  different	  extents	   to	   produce	   proteins51-­‐53.	   In	   another	   word,	   there	   is	   codon	   preference54	   or	  biased	  usage55	  when	  producing	  enzymes.	  Even	  though	  it	  was	  assumed	  that	  so-­‐called	  "silent"	  mutations	  than	  change	  which	  codon	  is	  present	  without	  changing	  the	  amino	  acid	  encoded	   	   	   should	  not	   cause	   changes	   in	  protein	   structures	  and	  activities	   since	  amino	   acids	   sequences	   are	   not	   changed,	   there	   are	   many	   groups	   dedicated	   to	  studying	  the	  effects	  of	  silent	  mutations.	  	  As	  early	  as	  the	  1980s,	  studies	  found	  that	  each	  codon	  has	  a	  cognate	  tRNA	  as	  an	   adaptor	   to	   recognize	   it,	   and	   the	  populations	   of	   the	  different	   tRNAs	   in	   cells	   are	  different55-­‐57.	   Natural	   selection	   tends	   to	   use	   the	   preferred	   codons	   with	   most	  abundant	   tRNA	   to	   increase	   translational	   efficiency	   and	   accuracy58-­‐60.	   In	   1987,	  Purvis’s	  group	  proposed	  that	  “the	  way	  in	  which	  some	  proteins	  fold	  is	  affected	  by	  the	  rates	   at	   which	   regions	   of	   their	   polypeptide	   chains	   are	   translated	   in	   vivo”61.	   The	  relationship	   between	   codon	   usage	   and	   protein	   translation	   rate	   in	  Escherichia	   coli	  was	   first	   characterized	  experimentally	   in	  198962.	  Not	  only	   the	   traffic	   of	   tRNA,	  but	  also	  the	  altered	  translation	  kinetics	  caused	  by	  synonymous	  codon	  substitutions	  may	  cause	  the	  same	  polypeptide	  chain	  to	  fold	  into	  different	  conformations,	  and	  thus	  alter	  the	  activity	  of	  the	  protein63.	  Recently,	  more	  and	  more	  studies	  have	  shown	  that	  silent	  mutations	  may	  cause	  genetic	  diseases64-­‐66.	  Therefore,	  silent	  mutations	  should	  not	  be	  neglected.	  	  In	  this	  project,	  the	  FeSOD	  gene	  was	  found	  to	  contain	  a	  spontaneous	  mutation	  (C43T).	   This	   mutation	   is	   silent	   since	   CTG	   and	   TTG	   are	   both	   codons	   for	   leucine.	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However,	  the	  behavior	  and	  activity	  of	  the	  FeSOD	  from	  the	  wild-­‐type	  and	  mutant	  are	  different,	   according	   to	   my	   experiments.	   The	   same	   silent	   codon	   substitution	   has	  recently	  been	  studied	  by	  another	  group.	  The	  study	  by	  Kimchi-­‐Sarfaty	  et	  al.	  showed	  that	   silent	   mutations	   in	   multidrug	   resistance-­‐1	   (MDR-­‐1)	   gene	   may	   affect	   the	  behavior	   of	   P-­‐glycoprotein,	   which	   is	   a	   multiple-­‐transmembrane	   helix	   pump	   that	  transports	   different	   drugs	   out	   of	   cancer	   cells65.	   They	   found	   that	   silent	   mutations	  have	   a	   slightly	   different	   three-­‐dimensional	   shape	   from	   the	   wild-­‐type	   protein.	  Another	   recent	   study	   showed	   that	   a	  CTG	   to	  TTG	  silent	  mutation	   in	   the	   immunity-­‐related	   GTPase	   family,	   M	   (IRGM)	   gene	   can	   alter	   the	   binding	   behavior	   miR-­‐196	  protein	  and	  contribute	  to	  Crohn’s	  disease66.	  	  
3.2	  Materials	  and	  Methods	  The	  correction	  of	  the	  silent	  mutation	  in	  the	  FeSOD	  gene	  was	  executed	  by	  site-­‐directed	  mutagenesis	  using	   the	   "QuikChange	  Lightning	  Kit”.	  Primers	   for	  PCR	  were	  ordered	   from	   Integrated-­‐DNA	  Technologies	   (IDT).	  Pfu	  Ultra	  Polymerase,	  Pfu	  Ultra	  HF	  reaction	  buffer,	  XL1-­‐Blue	  supercompetent	  cells	  were	  purchased	  from	  Stratagene.	  The	   gel	   extraction	   kit,	   QIAprep	   Spin	  miniprep	   kit	   and	   HiSpeed	   plasmid	  midi	   and	  maxi	  kits	  were	  purchased	  from	  QIAGEN.	  dNTP	  (deoxy	  nucleotide	  triphosphate)	  mix,	  Nde	   I,	   BamH	   I	   enzymes,	   100x	  BSA	   (bovine	   serum	  albumin),	  NEBuffer	   2,	   T4	   ligase	  buffer	   and	   T4	   DNA	   ligase	   were	   purchased	   from	   Bio-­‐rad.	   The	   polymerase	   chain	  reaction	   (PCR)	   was	   performed	   in	   a	   GeneAmp	   PCR	   System	   9700,	   with	   settings	  dependent	  optimized	  for	  the	  experiment	  (see	  below).	  	  FeSOD	  gene	  sequences	  were	  determined	   by	   sending	   plasmid	   DNA	   to	   Retrogen	   for	   nucleotide	   sequence	  determination	   based	   on	   primers	   recognizing	   the	   T7	   promoter	   and	   termination	  sequences.	  	  	  Electron	  paramagnetic	  resonance	  (EPR)	  was	  performed	  using	  a	  Bruker	  300MX	  EPR	  system	  operating	  at	  X-­‐band	  and	  an	  HS	  resonator	  cavity.	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Site-­‐directed	   mutagenesis	   was	   executed	   to	   correct	   a	   thymine	   identified	   in	  our	   overexpression	   vector	   back	   to	   the	   cytosine	   reported	   for	   the	   wild-­‐type	   (WT)	  gene.	  	   The	  forward	  primer	  5’-­‐cac	  tac	  cat	  atg	  cta	  aag	  atg	  ctc	  tgg	  cac	  cgc	  aca	  ttt	  ctg	  cgg	  aaa-­‐3’	  and	  reverse	  primer	  5’-­‐	  ttt	  ccg	  cag	  aaa	  tgt	  gcg	  gtg	  cca	  gag	  cat	  ctt	  tag	  cat	  atg	  gta	  gtg-­‐3’	  were	   used	   for	   the	  QuikChange	   site-­‐directed	  mutagenesis	   using	   the	   regimen	  which	   is	   described	   in	   Figure	   3.1.	   	   A	   51	   μL	   reaction	   (total	   volume)	  was	  made	   in	   a	  microamp	   reaction	   tube,	   containing	   5	   μL	   10X	   reaction	   buffer,	   2	   μL	   (76	   ng)	   DNA	  template,	   1.25	   μL(125	   ng)	   forward	   and	   reverse	   primers,	   1	   μL	   dNTP	   mixture	  (Stratagene),	   1.5	   μL	   QuikChange®	   Solution	   Reagent	   (Stratagene),	   1	   μL	  QuikChange®	   Lightning	   Enzyme	   (Strategene),	   and	   38	   μL	   sterile	   deionized	   water.	  The	  new	  ‘corrected’	  FeSOD	  gene	  was	  transformed	  into	  BL21	  (DE3)	  competent	  cells.	  Cells	   were	   spread	   on	   an	   LB	   plate	   containing	   50	   μg/mL	   kanamycin	   to	   select	   cells	  bearing	   the	   FeSOD	   plasmid.	   After	   incubation	   at	   37	   °C	   overnight,	   three	   single	  colonies	   plate	   were	   selected	   and	   each	   was	   used	   to	   inoculate	   a	   3	   mL	   LB	   culture	  containing	  50	  μg/mL	  kanamycin.	  After	   shaking	  at	  37	   °C	   for	  12	  hours,	   at	  250	  rpm,	  each	  culture	  was	  harvested	  by	  centrifugation	  and	  plasmid	  DNA	  was	  purified	  using	  the	   QIAprep	   Spin	   Miniprep	   Kit	   (Qiagen).	   The	   purified	   plasmid	   DNA	   was	   double	  digested	  with	  Nde	   I	   and	  BamH	   I,	   and	  analyzed	  by	  1%	  agarose	   gel	   electrophoresis	  with	  ethidium	  bromide	  (EB)	  (Figure	  3.2).	  The	  plasmids	  with	  the	  right	  size	  of	  insert	  (700	  bp)	  were	  selected	  for	  further	  characterization.	  A	  strain	  containing	  an	  apparently	  correct	  plasmid	  was	  grown	  in	  a	  100	  mL	  LB	  culture	  with	  50	  μg/mL	  kanamycin.	  After	  incubation	  at	  37	  °C	  for	  12	  hours,	  cells	  were	  harvested	   by	   centrifugation.	   The	   plasmid	   was	   purified	   using	   the	   QIAprep	   Spin	  Miniprep	   Kit	   (Qiagen),	   and	   sent	   to	   Retrogen	   Inc.	   for	   nucleotide	   sequence	  determination.	  
3.3	  Results	  
3.3.1	  Culture	  vigor	  and	  productivity	  (Growth	  curves	  and	  protein	  yield)	  The	   presence	   of	   a	   mutation	   in	   the	   FeSOD	   gene	   was	   suspected	   because	  induction	  of	  gene	  expression	  caused	  a	  sharp	  loss	  of	  culture	  vigor	  resulting	  in	  lower	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cell	  density	  after	  overnight	  growth.	  	  Upon	  isolation	  of	  the	  plasmid	  and	  sequencing	  of	  the	  FeSOD	  gene	  a	  spontaneous	  cytosine-­‐to-­‐thymine	  silent	  mutation	  was	  discovered	  in	   codon	   14.	   This	   mutation	   created	   a	   “TTG”	   codon	   instead	   of	   the	   WT	   “CTG”	   for	  leucine.	  Even	  though	  this	  mutation	  did	  not	  alter	  the	  identity	  of	  the	  encoded	  amino	  acid,	   which	   remained	   leucine,	   site-­‐directed	  mutagenesis	  was	   performed	   to	   covert	  the	   TTG	   codon	   back	   to	   the	   wild-­‐type	   CTG	   because	   the	   culture	   vigor	   and	   protein	  yields	   were	   low.	   Thus	   the	   described	   QuikChange	   procedure	   produced	   a	   L14L	  correction.	   In	   what	   follows	   the	   product	   of	   the	   spontaneously	   mutated	   gene	   is	  termed	  mutant	   FeSOD	  and	   the	  product	   of	   the	   corrected	   (WT)	   gene	   is	   termed	  WT	  FeSOD.	  Overexpression	  of	  the	  mutant	  gene	  caused	  the	  culture	  density	  to	  diminish	  in	  prolonged	   culture	   (Figure	   3.3).	   In	   contrast,	   cultures	   overexpressing	   the	   corrected	  gene	   sustained	   a	   high	   density	   over	   the	   same	   time	   period	   indicating	   that	   neither	  themetabolic	   burden	  of	   overexpression	  nor	   exhaustion	  of	   nutrients	  was	   to	  blame.	  Since	  a	  culture	  not	  overexpressing	  the	  mutant	  gene	  (blue	  squares	  in	  Figure	  3.3)	  did	  much	  better	  than	  a	  genetically	  identical	  culture	  overexpressing	  it	  (blue	  diamonds	  in	  Figure	  3.3),	  overexpression	  of	  the	  mutant	  gene	  causes	  the	  culture	  to	  loose	  vigor,	  not	  the	  gene	  itself.	  	  Thus	  it	  seemed	  possible	  that	  the	  protein	  produced	  from	  the	  mutant	  gene	  was	  detrimental.	  Four	   preparations	   from	   before	   and	   after	   mutagenesis	   were	   selected	   to	  calculate	  concentrations	  of	  iron	  and	  protein,	  and	  the	  iron	  contents	  (iron	  per	  dimer)	  and	  the	  protein	  yields	  from	  2	  L	  LB	  growths	  were	  determined	  (summarized	  in	  Table	  3.1).	  The	  FeSOD	  purified	  from	  cultures	  over-­‐expressing	  the	  mutant	  gene	  displayed	  a	  low	   iron	   stoichiometry	   of	   only	   one	   iron	   per	   protein	   dimer,	   vs.	   the	   expected	   two.	  FeSOD	  produced	  from	  the	  corrected	  gene	  contained	  50%	  more	  Fe	  and	  reached	  the	  theoretical	  iron	  content	  of	  2	  per	  dimer	  if	  cultures	  were	  allowed	  to	  continue	  growing	  overnight	  after	  induction	  of	  FeSOD	  gene	  expression,	  rather	  than	  being	  harvested	  4	  hours	  after	  addition	  of	  IPTG.	  Cultures	  expressing	  the	  mutant	  gene	  were	  not	  able	  to	  be	   harvested	   after	   overnight	   growth	   since	   the	   cultures	   had	   deteriorated	   so	   badly	  that	  proteins	   isolated	   from	  it	  could	  have	  been	  subject	   to	  degradation	  and	  damage.	  Therefore,	   it	   could	   not	   be	   reliably	   compared	   with	   protein	   isolated	   from	   stable	  cultures.	  Overnight	  growth	  following	  induction	  with	  IPTG	  almost	  doubled	  the	  yield	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of	  FeSOD	  from	  the	  corrected	  gene.	  Thus	  the	  fact	  that	  correction	  of	  the	  gene	  makes	  overnight	  induction	  possible	  greatly	  increases	  the	  yield	  attainable	  from	  a	  culture.	  Although	   correction	  of	   the	  gene	   resulted	   in	  greater	  Fe	   incorporation,	   it	  did	  not	  otherwise	  alter	  the	  specific	  activity	  of	  the	  FeSOD,	  since	  the	  activity	  on	  a	  per-­‐Fe	  basis	   was	   not	   different	   for	   FeSOD	   from	   the	   mutant	   gene	   vs.	   FeSOD	   from	   the	  corrected	  gene	  (Table3.2).	   	  Thus	  the	  mutant	  protein	  that	  binds	  Fe	  does	  not	  appear	  to	  have	  any	  defect	  (as	  expected	  for	  a	  silent	  mutation)	  although	  it	  is	  less	  efficient	  at	  acquiring	  Fe.	  Use	  of	   the	  WT	  gene	  however	  permitted	   longer	  growth	  of	   the	  culture	  and	   this	   in	   turn	   affects	   the	   extent	   to	   which	   harvested	   protein	   is	  mature	   enzyme.	  Thus	   cultures	   harvested	   after	   overnight	   growth	   in	   the	   presence	   of	   IPTG	   yielded	  FeSOD	  of	  considerably	  higher	  quality.	  	  
3.3.2	   Specific	   activity	   of	   FeSODs	   produced	   from	   the	   two	   genes	   (measured	   via	   the	  cytochrome	  C-­‐reduction	  interference	  assay13)	  In	   this	   assay	   SOD	   activity	   is	   assess	   indirectly	   via	   the	   ability	   of	   a	   sample	   to	  interfere	  with	  reduction	  of	  cytochrome	  C	  by	  O2•-­‐,	  which	   is	  monitored	  as	  growth	  of	  reduced	  cytochrome	  C's	  optical	  signal	  at	  550	  nm.	  O2−	   was	   generated	   by	   the	   reaction	   of	   xanthine	   and	   oxygen	   catalyzed	   by	  xanthine	  oxidase	  (XOD).	  𝑋𝑎𝑛𝑡ℎ𝑖𝑛𝑒 + 𝐻!𝑂 !"# 𝑈𝑟𝑖𝑐  𝑎𝑐𝑖𝑑 + 𝑂!! + 𝐻!                    (1)	  Oxidized	   cytochrome	   C	   was	   converted	   to	   the	   reduced	   form	   by	   the	   O2−	  produced	  by	  reaction	  (2).	  Oxidized	  cytochrome	  C	  +	  O2-­‐•	  →	  reduced	  cytochrome	  C	  +	  O2	   	   (2)	  When	   there	   was	   superoxide	   dismutase	   	   (SOD)	   in	   the	   system,	   O2−	   was	  consumed	  by	  SOD	  according	  to	  the	  reaction	  (3),	  which	  prevented	  O2−	  from	  reducing	  cytochrome	  C.	  	  	   2O!! + 2H! !"# O! + H!O!                    (3)	  Thus	   the	   presence	   of	   SOD	   activity	   resulted	   in	   a	   diminished	   rate	   of	  cytochrome	  C	  reduction	  as	  monitored	  at	  550	  nm.	  One	  unit	  of	  SOD	  activity	  is	  defined	  as	   the	   amount	   of	   SOD	   that	   halves	   a	   cytochrome	   c	   reduction	   rate	   equivalent	   to	   an	  absorbtion	  change	  at	  550	  nm	  of	  0	  .125/min.	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Figures	  3.4	  and	  3.5	  show	  the	  decrease	  in	  cytochrome	  C	  reduction	  caused	  by	  mutant	  and	  WT	  FeSOD.	  The	  decreases	  caused	  by	  several	  different	  amounts	  of	  FeSOD	  were	  used	  to	  calculate	  FeSOD	  activity.	  	  The	  number	  of	  activity	  units	  per	  mg	  protein	  is	  used	  as	  a	  measure	  of	  the	  specific	  activity	  of	  FeSOD.	  Table	  3.2	  shows	  the	  specific	  activities	   of	   different	   FeSOD	   preparations.	   Mutant	   FeSOD	   could	   not	   defeat	  superoxide	  for	  a	  long	  time.	  The	  cells	  from	  which	  this	  FeSOD	  was	  isolated	  were	  not	  vigorous	  and	  FeSOD	  activity	  was	  around	  8000	  units/mg.	  However,	  correction	  of	  the	  gene	  and	  increasing	  the	  cultivation	  time	  caused	  FeSOD	  activity	  to	  increase	  by	  more	  than	   100%.	   The	   resulting	   specific	   activity	   of	   19000	   is	   much	   higher	   than	   the	  published	  activities,	  which	  are	  in	  the	  range	  of	  8000-­‐11000.	  The	   specific	   activity	   of	   FeSOD	   from	   overnight	   inductions	   is	   some	   two-­‐fold	  higher	  than	  that	  normally	  reported	  in	  the	  literature37.	  
3.3.3	  Iron	  content	  of	  the	  active	  sites	  of	  FeSOD	  produced	  from	  the	  two	  genes	  We	   used	   two	   ways	   the	   determine	   iron	   concentration	   in	   vitro:	   optical	  spectroscopy,	  and	  the	  ferrozine	  assay67.	  Fe3+	   in	   the	   FeSOD	   active	   site	   has	   a	   ligand	   to	   metal	   charge	   transfer	   band	  characterized	  by	  an	  absorption	  maximum	  at	  350	  nm	  and	  an	  extinction	  coefficient	  of	  ε350	   =	   1850	   M-­‐1cm-­‐1	   37.	   Based	   on	   the	   absorbance	   at	   280	   nm	   and	   350	   nm,	   the	  concentration	   of	   protein	   and	   iron	   can	   be	   calculated	   (ε280	   =	   1.01×105	   M-­‐1cm-­‐1	   37).	  Figure	  3.6	  shows	  the	  absorbance	  spectra	  of	  FeSOD	  produced	  based	  on	   the	  mutant	  gene	  and	  the	  WT	  gene.	  This	  method	  quantifies	  only	  Fe3+	  in	  SOD.	  	  The	  other	  method	  is	  the	  ferrozine	  assay.	  Ferrozine,	  also	  called	  3-­‐(2-­‐pyridyl)-­‐5,6-­‐(4-­‐phenylsulfonic	   acid)-­‐1,2,4-­‐triazine,	   is	   a	   compound	   that	   can	   form	   a	   complex	  with	   Fe2+.	   The	   iron-­‐ferrozine	   complex	  displays	   a	   stable	  magenta	   color	   and	   can	  be	  quantified	   by	   spectrophotometry	   at	   562	   nm.	   This	   method	   can	   detect	   the	   total	  amount	  of	  iron	  (Fe2+and	  Fe3+)	  in	  samples	  after	  0.02%	  ascorbic	  acid	  had	  been	  used	  to	  reduce	   any	   Fe3+	   to	   Fe2+.	   The	  protein	  was	  precipitated	  using	  11.3%	   trichloroacetic	  acid	   and	   removed	   by	   centrifugation.	   Mixed	   ferroin	   color	   reagent	   (3	   mg/mL	  ferrozine,	   3	  mg/mL	   neocuproin)	  was	   added	   to	   the	   system	   to	   develop	   a	  magenta-­‐
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colored	  complex,	  the	  concentration	  of	  which	  was	  determined	  via	  the	  plot	  of	  known	  concentration	  of	  standard	  iron	  solutions	  at	  562	  nm67.	  Since	  WT	   FeSOD	   is	   a	   dimer,	   theoretically	   there	   should	   be	   2	   iron	   ions	   per	  dimer.	  Based	  on	  the	  low	  Fe3+	  stoichiometries,	  the	  metal	  uptake	  was	  incomplete	  for	  mutant	   FeSOD.	   There	   was	   always	   approximately	   one	   iron	   per	   dimer	   (Table	   3.3).	  After	   correction	   of	   the	   silent	   mutation	   the	   metal	   content	   was	   improved,	   and	  allowing	   growth	   to	   continue	   overnight	   after	   addition	   of	   IPTG	   resulted	   in	   a	   60%	  increase	   in	   yield	   and	   almost	   stoichiometric	   iron	   content.	   Thus,	   increasing	   the	  cultivation	  time	  after	  addition	  of	  IPTG	  significantly	  improves	  both	  the	  protein	  yield	  and	  the	  quality	  of	  the	  FeSOD.	  	  In	   conclusion,	   correction	   of	   the	   silent	  mutation	   improved	   the	   iron	   content	  and	  by	  permitting	  a	  longer	  cultivation	  time	  after	  addition	  of	  IPTG,	  increased	  yield	  of	  FeSOD	  we	  could	  obtain.	  Since	  the	  ferrozine	  assay	  detects	  all	  iron	  ions	  regardless	  of	  whether	  they	  are	  iron(II)	  or	   iron(III),	   the	   iron	  concentrations	  measured	  by	  the	  ferrozine	  assay	  were	  higher	  than	  those	  obtained	  from	  the	  A350,	  indicating	  that	  some	  of	  the	  iron	  in	  FeSOD	  was	  present	   as	   Fe2+.	   The	   iron	   content	   calculated	  by	   the	   ferrozine	   assay	  was	  often	  more	  than	  2,	  which	  means	  that	  there	  was	  nonspecific	  binding	  of	  iron	  ions	  outside	  of	  the	  protein	  active	  site.	  Incubation	  with	  0.5	  mM	  EDTA	  followed	  by	  a	  desalting	  using	  a	  G25	   column	  was	   used	   to	   remove	   the	   extra	   iron	   ions.	   After	   the	   treatment,	   the	   Fe	  stoichiometry	  of	  mutant	  FeSOD	  was	  0.63	  and	  that	  of	  the	  WT	  was	  1.40.	  
3.3.4	  Multiple	  forms	  of	  FeSOD	  depending	  on	  the	  gene	  from	  which	  it	  was	  produced	  
(Native	  gel	  (NBT	  assay)68	  Sodium	  dodecyl	  sulfate	  polyacrylamide	  gel	  electrophoresis	  (SDS-­‐PAGE)	  was	  used	  to	  identify	  the	  purity	  of	  FeSODs	  produced	  by	  mutant	  gene	  and	  wild	  type	  gene.	  Figure	   3.7	   shows	   the	   SDS-­‐PAGE	   result	   from	  both	   of	   the	   FeSODs.	   According	   to	   the	  SDS-­‐PAGE,	  both	  of	  the	  purified	  FeSODs	  were	  pure	  according	  to	  the	  only	  band	  in	  the	  gels.	  	   Non-­‐denaturing	   polyacrylamide	   gel	   electrophoresis	   was	   used	   to	   separate	  SOD	  from	  other	  proteins.	  FeSOD	  was	  localized	  by	  soaking	  the	  gels	  in	  2.45	  mM	  nitro	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blue	  tetrazolium	  (NBT)	  for	  20	  min,	  followed	  by	  immersion	  in	  a	  solution	  containing	  28	   mM	   tetramethylethylenediamine,	   28	   μM	   riboflavin,	   and	   36	   mM	   potassium	  phosphate	  at	  pH	  7.8	  for	  15	  min.	  The	  gels	  were	  then	  illuminated	  using	  a	  fluorescent	  lamp,	   causing	  photoexcited	   riboflavin	   to	   reduce	  O2	   and	  produce	  O2−	   (superoxide)	  that	  in	  turn	  reduced	  NBT	  to	  purple	  precipitate	  (blue	  formazan).	  However,	  positions	  with	  SOD	  do	  not	  change	  color,	  since	  O2−	  is	  consumed	  by	  SOD.	  Thus,	  the	  positions	  of	  active	  SOD	  are	  visible	  as	  dye-­‐free	  zones.	  Native	  gels	   stained	  using	   the	  NBT	  assay	  were	  used	   to	  compare	  mutant	  and	  WT	  FeSOD.	  Figure	  3.8	  shows	  that	  mutant	  FeSOD	  always	  migrated	  as	  2	  bands	  despite	  the	  fact	  that	  mutant	  protein	  ran	  as	  a	  single	  band	  in	  SDS	  PAGE.	  	  Although	  both	  bands	  posessed	  activity,	  the	  lower	  band	  was	  always	  smaller	  and	  had	  less	  activity	  than	  the	  upper	   band	   (Three	   separate	   growths	   and	   purifications	   yields	   mutant	   FeSOD	   in	  which	   the	   lower	   band	   contained	   1/3,	   1/3	   or	   1/10	   as	  much	   protein	   as	   the	   upper	  band,	  whereas	   the	   lower	  bands	  displayed	  only	  1/10	   to	  1/30	  activity	  as	   the	  upper	  band).	   Typical	   results	   are	   shown	   in	   Figure	   3.8.	   	   Even	   though	   the	   lower	   band	  concentration	   was	   about	   one	   half	   that	   of	   the	   upper	   band,	   according	   to	   the	  Coomassie-­‐brillian-­‐blue-­‐stained	  non-­‐denaturing	   gel,	   the	   activity	   of	   the	   lower	  band	  was	  much	   less	   than	   one	   half	   that	   of	   the	   upper	   band	   according	   to	   the	   NBT	   assay	  conducted	   on	   a	   duplicate	   gel.	   (Dilution	   series	   were	   run	   for	   each	   preparation	   to	  permit	  semi-­‐quantitative	  assessment	  of	  relative	  amounts	  of	  proteins	  in	  the	  different	  bands).	  However,	  after	  correction	  of	  the	  gene,	  there	  were	  significant	  differences	  with	  respect	   to	   the	   lower	   bands.	   The	   lower	   band	   decreased	   in	   significance	   or	   even	  disappeared.	  And	  the	  activity	  of	  the	  lower	  bands	  was	  still	  much	  less	  than	  that	  of	  the	  upper	   band,	   on	   a	   per-­‐protein	   basis.	   	   Since	   our	   assays	   of	   specific	   activity	   and	   Fe	  content	   (below)	   indicated	   that	   the	   WT	   protein	   was	   fully	   metallated,	   we	   could	  conclude	  that	  the	  upper	  bands	  were	  the	  native	  dimers	  of	  the	  wild-­‐type	  FeSOD.	  	  The	   silent	  mutation	  may	   change	   the	   structure	   of	   FeSOD,	   and	   affect	   the	   Fe	  content	   in	   each	   FeSOD	   dimer.	   Even	   though	   these	   two	   structures	   can’t	   be	  distinguished	  by	  SDS-­‐PAGE,	  they	  can	  be	  separated	  by	  the	  non-­‐denaturing	  gels.	  The	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structure	   corresponding	   to	   the	   lower	   bands	   in	   in	   the	   non-­‐denaturing	   gels	   has	   a	  lower	  activity	  on	  a	  per/protein	  basis	  than	  the	  upper	  bands	  and	  we	  had	  found	  that	  mutant	   FeSOD	   contained	   less	   Fe	   per	   protein	   dimer	   overall.	   Therefore,	   we	  hypothesized	  that	  there	  might	  be	  less	  Fe	  bound	  to	  the	  lower	  band	  protein.	  
3.3.5	  Iron	  content	  of	  the	  different	  forms	  of	  FeSOD	  (in-­‐gel	  stain)69	  The	   iron	   in	   SOD	   was	   localized	   by	   immersing	   the	   non-­‐denaturing	  polyacrylamide	  gels	  in	  which	  FeSOD	  had	  already	  been	  run	  in	  a	  solution	  containing	  50	   mM	   pH	   5.0	   sodium	   acetate,	   40	   mM	   hydrogen	   peroxide	   (H2O2)	   and	   80	   mM	  diaminobenzoic	  acid	  dihydrochloride	  at	  35	  °C	  for	  30	  min.	  The	  gels	  were	  then	  rinsed	  with	   7%	   acetic	   acid.	   In	   this	   process,	   any	   Fe	   present	   catalizes	   oxidation	   of	  diaminobenzoate	  by	  H2O2,	  	  producing	  an	  insoluble	  pigment	  in	  the	  gels.	  Comparison	   of	   in-­‐gel	   iron	   assay	   results	   for	   mutant	   and	   WT	   FeSODs	   are	  shown	  in	  Figure	  3.9.	  	  The	  gel	  that	  was	  stained	  with	  Fe	  was	  one	  of	  two	  identical	  gels,	  and	  the	  other	  was	  stained	  with	  Coomassie	  brilliant	  blue	  to	  review	  the	   locations	  of	  protein	  bands.	  	  Nitroreductase	  was	  used	  as	  a	  negative	  control	  since	  there	  is	  no	  iron	  in	  nitroreductase.	  Even	  though	  these	  gels	  revealed	  another	  protein	  above	  the	  band	  we	  refered	  to	  as	  the	  upper	  FeSOD	  band,	  there	  was	  no	  iron	  in	  that	  protein	  according	  to	  the	  stating	  applied	  (Figure	  3.9B).	  Based	  on	  the	  strong	  staining	  of	  the	  upper	  bands,	  there	  was	   clearly	   iron	  bound	   to	  all	   the	  dimers	  of	  wild-­‐type	  FeSOD.	   	  This	  was	  also	  true	  of	  the	  upper	  band	  of	  mutant	  FeSOD.	  The	  lower	  band	  of	  the	  mutant	  FeSOD	  had	  a	  shadowy	   pigmentation	   revealing	   bound	   iron	   based	   on	   the	   iron	   in-­‐gel	   assay,	   or	   at	  least	   some	   metal	   able	   to	   catalyze	   oxidation	   of	   diamino	   benzoate.	   However,	  comparison	  of	  the	  upper	  band	  of	  lane	  8	  with	  the	  lower	  band	  of	  lane	  3	  shows	  that	  the	  latter	  was	   less	  Fe	  on	  a	  per-­‐protein	  basis	   than	  does	   the	   former.	   	  Thus	  we	  conclude	  that	  the	  lower	  band	  is	  FeSOD	  that	  contains	  less	  than	  the	  full	  complement	  of	  Fe.	  
3.3.6	  Nature	  of	  Fe-­‐binding	  sites	  in	  FeSOD	  produced	  from	  the	  two	  FeSOD	  genes	  EPR	  
spectra	  EPR	   spectroscopy	   was	   used	   to	   assess	   the	   integrity	   of	   those	   sites	   that	   do	  acquire	   Fe,	   for	   the	   FeSOD	   produced	   based	   on	   the	  mutant	   gene	   and	   the	  WT	   gene.	  Figure	  3.10	  shows	  the	  spectra	  of	  two	  FeSODs	  at	  the	  same	  protein	  concentration.	  The	  spectra	  confirm	  the	  presence	  of	  Fe3+	  in	  both	  active	  sites.	  Since	  the	  major	  features	  in	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these	   two	  spectra	  occur	  at	   the	  same	   field	  strengths,	   they	   indicate	   that	  Fe3+	  adopts	  the	  correct	  coordination	  number	  and	  geometry	  in	  the	  protein	  from	  the	  mutant	  gene.	  However,	  FeSOD	  produced	  from	  the	  WT	  gene	  has	  more	  rhombic	  Fe3+	  (shoulder	  peak	  near	  1500	  G),	  which	  indicates	  that	  there	  is	  some	  Fe3+	  bound	  outside	  the	  active	  site	  on	  FeSOD	  produced	  by	  mutate	  gene.	  The	  active	  site	  peak	  is	  stronger	  than	  the	  non-­‐active	   site	   peak	   for	   FeSOD	   produced	   by	  WT	   gene	   however	   the	   reverse	   is	   true	   in	  FeSOD	  produced	  by	   the	  mutant	   gene.	  Moreover,	   the	  mutant	   gene	   FeSOD	  also	   had	  copper	   signature	   hyperfine	   splitting	   abound	   3000G	   than	   the	   FeSOD	   from	   the	  WT	  gene,	  indicating	  that	  the	  mutant	  gene	  FeSOD	  may	  have	  acquired	  some	  copper	  from	  the	  medium.	   Since	   the	   protein	   dimer	   concentrations	   for	   both	   the	   SODs	   were	   the	  same,	  the	  EPR	  spectral	  results	  were	  consistent	  with	  the	  optical	  spectra,	  which	  also	  indicated	  that	  the	  active	  site	  Fe3+	  concentration	  in	  FeSOD	  produced	  based	  on	  the	  WT	  gene	  was	  twice	  that	  in	  FeSOD	  produced	  by	  the	  mutant	  gene	  (Table	  3.1).	  	  
3.3.7	  Secondary	  and	  tertiary	  structure	  of	  FeSODs	  made	  from	  the	  two	  genes	  The	  secondary	  and	  tertiary	  structures	  of	  FeSODs	  produced	  from	  the	  mutant	  gene	  and	  the	  corrected	  WT	  gene	  were	  assessed	  by	  circular	  dichroism	  (CD).	  The	  far-­‐UV	   (ultraviolet)	   CD	   spectra	   of	   these	   two	   FeSODs	   are	   shown	   in	   Figure	   3.11.	  According	  to	  the	  spectra,	  the	  FeSODs	  have	  similar	  secondary	  structures	  and	  showed	  strong	  features	  characteristic	  of	  α-­‐helical	  content	  in	  the	  far-­‐UV	  region.	  The	  near-­‐UV	  CD	  spectra	   in	  Figure	  3.12	  provide	   information	  on	   the	   tertiary	  structure	  of	  FeSODs	  via	   the	   intrinsic	  CD	  of	   tryptophans.	  According	   to	   the	  FeSOD	  amino	   acid	   sequence,	  there	  are	  11	  phenylalanines	  (F),	  9	  tyrosines	  (Y),	  and	  7	  tryptophans	  (W),	  which	  make	  up	   the	   absorptions	   around	   280	   nm	   in	   near-­‐UV	   CD.	   	   However	   tryptophan	   has	   a	  higher	  intrinsic	  optical	  activity	  and	  extinction	  coefficient	  so	  the	  signal	  is	  dominated	  by	  tryptophans.	  
3.4	  Discussion	  
3.4.1	  Rare	  codon	  of	  silent	  mutation	  The	  diminution	  of	   culture	  vitality	  over	   longer	  culture	   times	  and	   the	   low	  Fe	  incorporation	   into	   an	   over-­‐expressed	   FeSOD	  was	   noticed	   at	   the	   beginning	   of	   the	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project.	   Upon	   re-­‐isolation	   of	   the	   overexpression	   plasmid	   from	   these	   cultures	   and	  sequencing	  of	  the	  FeSOD	  gene,	  we	  found	  out	  there	  was	  a	  L14L	  silent	  mutation.	  Overexpression	  of	   the	  wild-­‐type	  SOD	  gene	  had	  no	  deleterious	  effect,	   so	   the	  decline	   of	   the	   culture	   expressing	   the	   mutant	   gene	   was	   not	   due	   to	   the	   metabolic	  burden	  of	  gene	  expression	  per	  se.	  The	  only	  difference	  between	  the	  two	  genes	  is	  that	  the	   mutant	   gene	   employs	   a	   different	   codon	   for	   Leu14,	   so	   we	   conclude	   that	   the	  effects	  on	  the	  culture	  are	  due	  to	  that	  codon’s	  identity.	  	  The	   silent	   mutation	   in	   our	   FeSOD	   gene	   replaces	   a	   common	   codon	   (CTG	  accounts	  for	  55%	  of	  leucine	  condons	  in	  E.	  coli70)	  with	  a	  rare	  one	  (TTG	  accounts	  for	  11%	  of	  leucine	  in	  E.	  coli).	  Rare	  codon	  use	  has	  been	  shown	  to	  cause	  higher	  levels	  of	  abortive	  translation	  resulting	  in	  diminished	  yields	  of	  gene	  product56,58-­‐60.	  Either	  the	  tRNA	   or	   the	   aminoacyl-­‐tRNA	   synthase	   needed	   for	   translation	   of	   that	   codon	   may	  become	   limiting	  when	   a	   gene	   employing	   a	   rare	   codon	   is	   strongly	   expressed,	   as	   is	  done	  when	  over-­‐producing	  a	  protein.	  Not	  only	  will	  production	  of	   the	   sought-­‐after	  protein	   be	   compromised,	   but	   so	   also	   will	   be	   production	   of	   all	   other	   proteins	  dependent	  on	  that	  codon.	  This	  can	  explain	  why	  presence	  of	  the	  rare	  codon	  does	  not	  decrease	  culture	  health	  when	  the	  gene	  is	  repressed,	  but	  causes	  culture	  decline	  when	  the	  gene	  is	  expressed.	  
3.4.2	  Activity	  and	  Fe	  incorporation	  Electrophoresis	   under	   non-­‐denaturing	   conditions	   revealed	   that	   FeSOD	  preparations	  produce	  at	  least	  two	  forms	  of	  FeSOD.	  Of	  the	  two	  dominant	  forms,	  the	  lower	  band	  accounts	  for	  almost	  half	  of	  FeSOD	  produced	  by	  the	  mutant	  gene	  but	  only	  a	  very	  minor	   fraction	  of	   the	  protein	   for	  FeSOD	  produced	   from	  the	  corrected	  gene.	  	  Moreover	  the	  lower	  band	  contributed	  a	  negligible	  portion	  of	  the	  catalytic	  activity	  of	  FeSOD	  from	  the	  WT	  gene.	  The	   situation	   is	   more	   complicated	   for	   FeSOD	   produced	   from	   the	   mutant	  gene.	  While	  the	  lower	  band	  does	  not	  produce	  a	  discrete	  dye-­‐free	  zone	  such	  as	  that	  produced	  by	  the	  upper	  band,	  there	  is	  extensive	  streaking	  between	  the	  two	  positions	  and	  the	  position	  of	  the	  lower	  band	  displays	  a	  marked	  increase	  in	  the	  amount	  of	  dye.	  The	  streak	  between	  the	  positions	  of	  the	  two	  bands	  might	  correspond	  to	  protein	  with	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properties	  intermediate	  between	  those	  in	  the	  two	  bands,	  but	  it	  is	  interesting	  to	  note	  the	   streak’s	   virtual	   absence	   from	   FeSOD	   expressed	   based	   on	   the	   WT	   gene.	   The	  increase	   in	   dye	   density	   right	   at	   the	   position	   of	   the	   lower	   band	   suggests	   that	   this	  protein	  actually	  produces	  superoxide	  or	  otherwise	  favors	  some	  reaction	  with	  NBT.	  Indeed	   the	  darkened	  oval	  on	   the	  bottom	  edge	  of	   the	   streak	  can	  be	   seen	  by	  eye	   to	  have	  a	  slightly	  pinker	  color	  than	  the	  bluer-­‐purple	  of	  the	  dye	  formed	  elsewhere	  in	  the	  gel.	  In	  any	  case,	  the	  SOD	  activity	  of	  the	  lower	  band	  is	  lower	  than	  expected	  based	  on	  the	  amount	  of	  protein	  at	  that	  position	  for	  both	  FeSODs,	  and	  the	  amount	  of	  protein	  in	  the	  lower	  band	  is	  significantly	  greater	  for	  FeSOD	  based	  on	  the	  mutant	  gene.	  	  When	   gels	   were	   stained	   with	   diaminobenzoic	   acid	   to	   visualize	   Fe,	   it	   was	  apparent	   that	   the	   lower	   band	   possesses	  much	   less	   Fe	   on	   a	   per-­‐protein	   basis.	   For	  example	  based	  on	  the	  amount	  of	  protein	  in	  the	  lower	  band	  of	  FeSOD	  produced	  from	  the	   mutant	   gene,	   one	   expects	   similar	   amounts	   of	   Fe	   in	   the	   two	   bands	   as	   well.	  However	  the	  corresponding	  lane	  reveals	  much	  less	  Fe	  in	  the	  lower	  band	  than	  in	  the	  upper	  band.	  The	  location	  of	  the	  Fe	  coincides	  with	  the	  apparent	  pro-­‐oxidant	  activity	  of	  FeSOD	  produced	  from	  the	  mutant	  gene.	  The	   large	   improvement	   in	   Fe	   stoichiometry	   observed	   upon	   extending	   the	  post-­‐IPTG	   growth	   interval	   from	   4	   hours	   to	   overnight	   is	   consistent	   with	   the	  decreased	  population	  of	  lower	  band	  in	  conjunction	  with	  the	  lower	  band’s	  lower	  Fe	  content.	  Thus,	   increased	  production	  of	  a	  Fe-­‐poor	  second	  species	   (lower	  band)	  can	  account	  for	  the	  lower	  Fe	  content	  of	  FeSOD	  from	  the	  mutant	  gene	  as	  well	  as	  its	  lower	  activity.	  People	  may	  argue	  that	  chromosomal	  SOD	  may	  count	  for	  some	  of	  the	  activity,	  since	   the	   strain	   used	   in	   the	   project	   does	   express	   its	   own	   chromosomal	   SOD.	  However,	   the	   SOD	   from	   chromosomal	   gene	   and	   plasmid	   gene	   can	   be	   quantified	  according	  to	  the	  SDS-­‐PAGE	  before	  and	  after	  IPTG	  induction.	  Before	  IPTG	  induction,	  there	  was	  no	  more	  than	  5%	  of	  total	  SOD	  producing	  after	  IPTG	  showing	  in	  the	  SDS-­‐PAGE	  (Figure	  3.13),	  indicating	  that	  the	  chromosomal	  SOD	  contribute	  less	  than	  5%	  of	  SOD	  activity.	  	  Quantitation	  of	  Fe	  showed	  that	  FeSOD	   from	  the	  WT	  gene	   incorporates	   iron	  atoms	   in	   every	   active	   site	   when	   grown	   overnight	   following	   addition	   of	   IPTG	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whereas	   the	   maximum	   amount	   of	   Fe	   incorporated	   in	   FeSOD	   produced	   from	   the	  mutant	  gene	  was	  only	  1	  Fe	  per	  dimer.	  It	   is	  also	  possible	   that	  Fe	   is	  not	  bound	  correctly	   in	  FeSOD	   from	  the	  mutant	  gene.	   EPR	   spectra	   and	   optical	   spectra	   for	   the	   FeSODs	   produced	   from	   the	  mutant	  gene	  and	  the	  WT	  gene	  were	  compared	  and	  consistent	  with	  one	  another.	  	  The	  optical	  spectrum	  of	  FeSOD	  produced	   from	  the	  mutant	  gene	  showed	  a	  weaker	  signal	   from	  Fe3+	  but	  the	  absorption	  maximum	  was	  the	  same	  as	  that	  of	  FeSOD	  from	  the	  mutant	  gene,	   as	  was	   the	   overall	   shape	   of	   the	   signal.	   	   Similarly,	   the	   EPR	   signals	   of	   FeSOD	  from	  the	  mutant	  gene	  and	  the	  WT	  gene	  reveal	  similar	  coordination	  environments,	  but	   they	   suggest	   that	  a	   larger	   fraction	  of	   the	  Fe	  bound	   to	  FeSOD	   from	   the	  mutant	  gene	   is	   not	   coordinate,	   and	  may	   even	   be	   bound	   outside	   the	   active	   site.	   Thus	   the	  lower	  amount	  of	  Fe	  present	  can	  account	   for	   the	   lower	  activity	  of	  FeSOD	  produced	  from	   the	  mutant	   gene,	   but	   the	   presence	   of	   a	   small	   population	   of	   non-­‐native	   sites	  may	  also	  contribute	  to	  the	  relative	  lack	  of	  activity.	  Incorrect	  or	  incomplete	  metal	  ion	  binding	  could	  cause	  or	  result	  from	  a	  non-­‐native	  structure.	  	  However	  the	  CD	  spectra	  do	   not	   reveal	   any	   different	   in	   the	   secondary	   structural	   content	   of	   FeSOD	   or	   the	  environment	  of	  the	  tryptophan	  side	  chains.	  
3.4.3	  Structure	  change	  by	  silent	  mutation	  According	  to	  the	  primary	  sequence	  of	  FeSOD,	  the	  leucine14	  silent	  mutation	  is	  located	   in	   the	  beginning	  of	  N-­‐terminus.	  When	   ribosome	  produces	   the	  protein,	   the	  formation	   of	   leucine14	   precedes	   any	   of	   the	   Fe	   ligand	   amino	   acids.	   From	   the	  secondary	   structure,	   the	   side	   chain	   of	   leucine14	   is	   in	   the	   middle	   of	   a	   small	  hydrophobic	   cluster.	   This	   small	   hydrophobic	   cluster	   is	   located	   between	   the	   two	  domains,	  and	  brings	  the	  N-­‐terminal	  helix	  and	  the	  last	  helix	  in	  C-­‐terminus	  together.	  As	  we	  know,	  the	  Fe	  active	  site	  is	   located	  between	  the	  two	  domains,	  any	  effect	  that	  brings	  the	  two	  domains	  together	  will	  favorite	  the	  Fe	  incorporation.	  We	  propose	  that	  the	  usage	  of	  rare	  codon	  TTG	  may	  slow	  down	  the	  speed	  of	  FeSOD	  peptide	  synthesis,	  since	  either	  the	  tRNA	  or	  the	  aminoacyl-­‐tRNA	  synthase	  needed	  for	  translation	  of	  that	  codon	  may	  become	  limiting	  when	  a	  gene	  employing	  a	  rare	  is	  strongly	  expressed,	  as	  is	  done	  when	  over-­‐producing	  the	  protein.	  At	  the	  same	  time,	  the	  N-­‐terminus	  peptide	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before	   Leu14	   may	   adapt	   another	   structure.	   When	   synthesis	   is	   finished,	   the	  hydrophobic	  cluster	  formed	  around	  the	  Leu14	  may	  have	  less	  ability	  to	  bring	  the	  two	  domains	   together,	   and	   then	   affect	   the	   active	   site	   Fe	   incorporation.	   On	   the	   other	  hand,	  when	  the	  silent	  mutation	  has	  been	  corrected	  by	  site-­‐directed	  mutagenesis,	  the	  speed	   of	   peptide	   synthesis	   is	   not	   hindered,	   and	   FeSOD	   can	   fold	   the	   right	   second	  structure,	  and	  incorporate	  the	  Fe	  atom	  well.	  	  Even	   though	   is	   not	   observed	   in	   metalloenzyme	   like	   FeSOD,	   a	   paper	  describing	  another	  protein	  in	  2007	  Science65	  is	  in	  the	  similar	  situation	  as	  our	  case.	  The	   researchers	   found	   out	   that	   some	   cancer	   patients	   develop	   resistance	   to	  chemotherapy	   during	   cancer	   treatment,	   and	   this	   led	   them	   to	   discover	   a	   silent	  mutation	  in	  P-­‐glycoprotein,	  called	  multidrug	  resistance	  1	  (MDR1).	  The	  rare	  codon	  of	  silent	  mutation	   led	  to	  a	  change	   in	  the	  mRNA,	  and	  caused	  the	  ribosome	  slow	  down	  the	   speed	  of	  protein	   synthesis71.	  The	  author	   stated	   that	   the	  N-­‐terminal	  proregion,	  which	   synthesized	   before	   the	   silent	  mutation	  may	   play	   a	   role	   as	   “intra-­‐molecular	  chaperone”	   (IMC),	   which	   can	   change	   the	   energy	   landscape,	   and	   further	   lead	   the	  protein	  to	  adopt	  another	  conformation	  rather	  than	  the	  native	  form.	  Amazingly,	  the	  original	   intention	   to	  discover	   this	   silent	  mutation	  has	  a	   surprising	   resemblance	   to	  our	   case.	   Just	   as	   us,	   their	   research	   “started	  with	   an	   expression	  problem”72.	  At	   the	  beginning	  of	   the	   research,	   they	  had	   a	  hard	   time	   to	   express	   large	  quantities	   of	   the	  protein	  in	  bacterial	  cells.	  They	  found	  out	  a	  codon	  replacement	  (ATC	  to	  ATT)	  existed,	  but	   they	  were	  both	  encode	   the	  same	  amino	  acid	   isoleucine.	   	  Even	   though	   through	  the	  past	  generations,	  scientists	  assumed	  that	  silent	  mutations	  don’t	  change	  proteins’	  function,	  more	   and	  more	   clinical	   data	   show	   that	   these	   silent	  mutations	   can	   cause	  some	   kinds	   of	   disorders	   or	   diseases.	   So	   maybe	   there	   is	   purpose	   to	   use	   frequent	  codons	   for	  highly	   expressed	  proteins	  by	  nature,	  which	   is	  making	   sure	   the	  protein	  making	  and	  folding	  process	  faster	  and	  more	  accurate.	  Another	   convincing	   example	   is	  published	   in	  2011	  by	  Brest	  et	  al.	   in	  Nature.	  The	  silent	  mutation	  they	  found	  is	  the	  same	  with	  our	  silent	  mutation	  in	  FeSOD,	  which	  is	  a	  CTG	  to	  TTG	  mutation	  for	  leucine	  in	  the	  coding	  region	  of	  a	  gene	  called	  “immunity	  related	  GTPase	  family,	  M”	  (IRGM	  protein).	  And	  they	  found	  that	  this	  silent	  mutation	  is	  associated	  with	  Crohn’s	  disease.	  They	  proposed	  that	  the	  usage	  of	  rare	  codon	  may	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interfere	   the	   rhythms	  of	  RNA	  passing	   through	   the	   ribosome,	   and	   further	   interfere	  the	  protein	  folding66.	  	  
3.4.4	  Insight	  of	  the	  project	  Silent	   mutations	   are	   assumed	   to	   be	   silent	   in	   the	   past	   years,	   since	   these	  mutations	  would	   not	   change	   the	   protein	   amino	   acid	   sequences.	  Without	   knowing	  the	   gene’s	   nucleotide	   sequence,	   the	   biochemist	   Herbert	   Boyer	   synthesized	   the	  human	   hormone	   somatostatin	   by	   using	   E.	   coli	   favored	   codons73.	   And	   this	   event	  became	  a	  milestone	  in	  the	  development	  of	  biotechnology.	  Since	  then,	  making	  silent	  mutations	  in	  the	  gene	  sequence	  became	  a	  very	  important	  and	  standard	  practice	  in	  pharmaceutical	  industry.	  That’s	  why	  more	  and	  more	  gene	  therapies,	  antibodies	  and	  vaccines	   are	   produced	   based	   on	   adapting	   synonymous	   codons.	   Some	   of	   the	   gene	  sequences	  of	  the	  constructed	  proteins	  may	  be	  altered	  by	  as	  much	  as	  80%	  from	  their	  native	   forms72.	   However,	   in	   the	   past	   few	   years,	   people	   found	   out	   that	   silent	  mutations	  may	  have	  effect	  on	  human	  health.	  Just	  as	  the	  introduction	  indicated,	  more	  and	   more	   groups	   are	   dedicated	   to	   study	   silent	   mutations.	   For	   example,	   most	  recently	   in	   the	   Nature	   magazine,	   Brest,	   P.	   et	   al.	   found	   out	   the	   leucine	   to	   leucine	  silent	   mutation	   may	   affect	   IRGM	   gene	   expression	   and	   associate	   with	   Crohn’s	  disease;	   and	   another	   paper	   in	   the	   Science	   magazine	   by	   Kimchi-­‐Sarfaty	   et	   al.	  indicated	   that	   silent	   mutations	   may	   cause	   multidrug	   resistance	   protein	   behave	  differently	   in	   cancer	   cells.	   However,	   neither	   of	   the	   two	   cases	   is	   about	  metalloenzymes	  like	  FeSOD.	  	  Our	  project	  mainly	   focuses	  on	  the	   fact	   that	   the	  Leu14Leu	  mutation	  affected	  the	   metalloenzyme	   FeSOD	   maturation	   and	   active	   site	   metal	   Fe	   incorporation.	   In	  order	   to	   find	   out	   whether	   there	   is	   any	   research	   about	   this	   field	   going	   on	   in	   the	  world,	  a	  drastically	  web-­‐searching	  was	  executed	  through	  Web	  of	  Knowledge.	  Even	  though	  there	  are	  8139	  hints	  about	  “silent	  mutation”	  in	  the	  whole	  timespan,	  there	  is	  no	  hint	  related	  to	  “silent	  mutation”	  and	  “metal	  incorporation”,	  “silent	  mutation”	  and	  “metalloenzyme”,	   or	   “silent	   mutation”	   and	   “maturation”.	   There	   are	   only	   21	   hints	  related	  to	  “silent	  mutation”	  and	  “superoxide	  dismutase”.	  Among	  the	  21	  hints,	  there	  are	  only	  7	  papers	  addressed	  the	  issue	  of	  silent	  mutations	  in	  SOD74-­‐80.	  All	  of	  them	  are	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related	   to	   copper/zinc	   SOD	   (Cu/ZnSOD).	   Among	   these	   papers,	   some	   of	   them	  concluded	  that	  silent	  mutation	  may	  have	  effect	  on	  the	  characteristics	  of	  Cu/ZnSOD,	  some	   of	   them	   addressed	   that	   the	   effect	   remained	   to	   be	   further	   explained.	   For	  example,	   Campo,	   S.	   et	   al.	   had	   reported	   that	   the	   silent	   mutation	   (GCG	   to	   GCT)	  encoded	   alanine	   of	   Mediterranean	   population	   had	   no	   significant	   effect	   on	   the	  protein	   activity	   and	   it	   may	   not	   related	   to	   several	   diseases,	   such	   as	   diabetes	   and	  atherosclerosis78.	  On	  the	  other	  hand,	  another	  paper75	  addressed	  an	  A140A	  (GGT	  to	  CCA)	   silent	   mutation	   was	   associated	   with	   familial	   amyotrophic	   lateral	   sclerosis	  disease	  (FALS).	  The	  author	  proposed	  that	  the	  mutated	  mRNA	  might	  be	  cytotoxic	  of	  the	   silent	   mutation.	   Therefore,	   whether	   silent	   mutations	   can	   affect	   Cu/ZnSOD	  activity	  is	  very	  controversial.	  	  However,	  as	   far	  as	  our	  knowledge,	  the	  thesis	   is	  the	  first	  time	  to	  publish	  the	  relationship	  of	  silent	  mutation	  and	  the	  metalloenzyme	  FeSOD	  maturation/activity.	  It	  shows	   that	   the	   silent	  mutation	   did	   affect	   the	   FeSOD	  maturation,	   Fe	   incorporation	  and	  the	  protein	  activity.	  This	  new	  discovery	  may	  reveal	  a	  new	  relationship	  between	  silent	  mutations	  and	  FeSOD	  protein.	  Hopefully,	  people	  may	  not	  ignore	  the	  sound	  of	  mutation	  any	  more	  in	  the	  near	  future.	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Table	  3.1:	  Metal	  contents	  and	  FeSOD	  yield	  from	  different	  preparations.	  
 Gene 
correction 
Duration of growth after 
addition of IPTG  
[Fe]/[dimer]* Yield from 2L 
growth/mg 
1st preparation no 4 hours 1.05 80 
3rd preparation no 12 hours 0.81 90 
5th preparation yes 4 hours 1.53 90 
6th preparation yes 12 hours 1.92 150 *Concentrations	  were	  calculated	  based	  on	  A350	  and	  A280	  	  	  
Table	  3.2:	  Comparison	  of	  FeSOD	  from	  the	  mutant	  and	  WT	  gene.	  	   [Fe]/dimer by A350	   Activity	  (U/mg)*	   Activity/Fe	  (U/mg)*	  
silent	  mutant	  a	   0.9±0.2	   8400	   9000	  




Table	  3.3:	  Iron	  content	  based	  on	  the	  A350	  and	  ferrozine	  assay.a	  
 [Fe]/dimer by 
A350 
[Fe]/dimer by ferrozine 
assay  
silent mutant b 0.9±0.2 0.6±0.2 
WT (Corrected) c 1.7±0.2 1.4±0.2 a	  	  Data	  were	  collected	  after	  EDTA	  treatment.	  b	  The	  culture	  was	  harvested	  4	  hours	  post	  IPTG.	  c	  The	  culture	  was	  harvested	  after	  overnight	  growth	  post	  IPTG.	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Figure	  3.1:	  PCR	  program	  for	  site-­‐directed	  mutagenesis	  the	  FeSOD	  gene	  	   	  	  	  
	  
Figure	   3.2:	   1%	   agarose	   gel	   analysis	   of	   FeSOD	   gene-­‐bearing	   plasmid	   after	   double	  digestion	  with	  Nde	   I	   and	   BamH	   I.	   Lane	   1,	   the	   DNA	   ladder	   (GeneRuler™	   1kb	  DNA	  ladder	  from	  Fermentas).	  Lanes	  2	  to	  4	  were	  the	  double	  digestion	  of	  plasmid	  from	  3	  cultures	  inoculated	  with	  three	  colonies,	  individually.	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Figure	   3.3:	  Growth	   curves	  before	  and	  after	  mutagenesis.	  The	  arrows	   indicate	   the	  addition	  of	  IPTG.	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Figure	  3.5:	  Cytochrome	  C-­‐reduction	  assay	  for	  the	  WT	  gene	  FeSOD.	  Decrease	  in	  rate	  of	  cytochrome	  C	  reduction	  due	  to	  superoxide	  consumption	  by	  FeSOD.	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Figure	  3.7:	  SDS-­‐PAGE	  for	  FeSODs	  produced	  by	  mutant	  gene	  (Panel	  A)	  and	  wild	  type	  gene	  (Panel	  B).	  Lane	  1	  in	  panel	  A	  is	  Kaleidoscope	  Prestained	  Standards	  (310006790,	  from	  BIO-­‐RAD);	   lane	  1	   in	  panel	  B	   is	  Prestained	  SDS-­‐PAGE	  Standards	   (310006667,	  from	  BIO-­‐RAD).	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Figure	  3.9:	  Iron	  in-­‐gel	  assay	  for	  “before	  site-­‐directed	  mutagenesis”	  preparation	  and	  “after	   site-­‐directed	  mutagenesis”	   preparation.	   Panel	   A	  was	   native	   gel	   soaked	   into	  Coomassie	  Blue;	  Panel	  B	  was	  the	  gel	  soaked	  in	  iron	  detecting	  buffers.	  Lane	  1	  was	  the	  molecular	  weight	  ladder;	  Lane	  2	  was	  nitroreductase	  (negative	  control);	  Lane	  3	  was	  purified	  FeSOD	  without	  dilution	  from	  the	  1st	  preparation;	  Lanes	  4	  and	  5	  were	  3-­‐	  and	  30-­‐	  fold	  dilution	  of	  the	  material	  loaded	  in	  lane	  3;	  Lane	  6	  was	  purified	  FeSOD	  without	  dilution	  from	  the	  6th	  preparation;	  Lanes	  7	  and	  8	  were	  3-­‐	  and	  30-­‐	  fold	  dilution	  of	  the	  material	  loaded	  in	  lane	  6.	  	  
	  
Figure	   3.10:	   EPR	   spectra	   for	   the	   FeSODs	   produced	   based	   on	   mutant	   gene	   and	  corrected	  gene.	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Figure	  3.11:	  Far-­‐UV	  spectra	  of	  FeSODs	  produced	  by	  the	  mutant	  and	  wild-­‐type	  gene.	  
	  	  
Figure	   3.12:	   Near-­‐UV	   spectra	   of	   FeSODs	   produced	   by	   the	   mutant	   and	   wild-­‐type	  gene.	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CONCLUSIONS	  In	  this	  project,	  E.	  coli	  strain	  pRK3-­‐1	  was	  grown,	  and	  FeSOD	  was	  purified.	  In	  order	   to	   obtain	   good	   yield	   and	   high	   quality	   FeSOD,	   the	   conditions	   of	   growth	   and	  purification	  were	   optimized.	   0.5	  mmol/L	   final	   concentration	   of	   IPTG	  was	   used	   to	  overexpress	  the	  FeSOD	  gene.	  Different	  amounts	  of	  aeration	  also	  affected	  the	  yield	  of	  FeSOD.	  2	  L	  LB	  medium	  in	  6	  L	  flask	  was	  found	  to	  have	  a	  good	  amount	  of	  oxygen	  to	  improve	  culture	  yield.	  	  Even	  using	  the	  optimized	  condition,	  the	  FeSOD	  activity	  and	  Fe	  content	  were	  not	   satisfied.	   After	   sequencing	   the	   FeSOD	   gene,	   a	   silent	  mutation	  was	   found,	   and	  corrected	   through	   the	  use	  of	   site-­‐directed	  mutagenesis.	  Upon	   the	  gene	   correction,	  the	   iron	   content	  was	   improved	   from	  around	  1	   to	   close	  2,	  which	   is	   the	   theoretical	  iron	  content	  in	  FeSOD.	  The	  native	  gels,	  NBT	  assay,	   iron	  in-­‐gel	  stain	  assay,	  and	  EPR	  spectra	  support	  this	  result.	  CD	  spectra	  were	  applied	  to	  prove	  that	  the	  two	  FeSODs	  have	  the	  similar	  secondary	  and	  tertiary	  structures.	  The	   purification	   process	   eliminates	   the	   undesired	   protein.	   Different	  temperature	  of	  heat-­‐cut	  were	  tested,	  and	  50	  °C	  was	  used	  throughout	  the	  following	  preparations.	  SDS-­‐PAGE	  gels	  were	  used	  to	  visualize	  the	  purification	  process	  and	  the	  purity	  of	  FeSOD.	  	  After	  site-­‐directed	  mutagenesis,	  overnight	  growth	  following	  addition	  of	  IPTG	  increased	   both	   FeSOD	   yield	   and	   its	   activity.	   Compared	  with	   5	   hours	   growth	   post	  IPTG,	   overnight	   growth	   following	   the	   addition	   of	   IPTG	   can	   provide	   60%	   higher	  protein	   yield	   and	   50%	   higher	   activity.	   We	   speculate	   that	   after	   site-­‐directed	  mutagenesis	   and	   longer	   time	  growth,	   there	   are	  more	   tRNAs	   to	  utilize	  by	   the	   cells	  and	  able	  to	  form	  correct	  protein	  structure	  and	  uptake	  metal	  iron.	  	  Even	  there	  are	  several	  papers	  published	  recently	   that	  silent	  mutations	  may	  affect	  the	  structures	  and	  activities	  of	  proteins,	  and	  cause	  some	  of	  diseases49,65,	  there	  is	  no	  such	  paper	  studying	  metalloenzymes.	  	  According	  to	  the	  web	  search	  up	  to	  date,	  there	  is	  no	  such	  study	  about	  FSOD,	  and	  this	  thesis	  may	  be	  the	  first	  time	  to	  publish	  the	  relationship	  between	  silent	  mutation	  and	  maturation/activity	  of	  FeSOD.	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